share_log

BioAffinity Technologies Shares Are Trading Higher After the Company Announed the Publication of Results of Its Clinical Trial in Peer-reviewed Journal Respiratory Research.

Benzinga ·  Jan 24, 2023 21:56
BioAffinity Technologies shares are trading higher after the company announed the publication of results of its clinical trial in peer-reviewed journal Respiratory Research.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment